ArticleDiabetes, obesity & metabolism2019

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.

Stephen C Bain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.